🧬 This week our Senior Research Scientist Rosalba Perrone , Ph.D presented exciting new data from our CD38 inhibitor program at the 2025 Gordon Research Conferences on the Biology of Aging, alongside co-authors from our collaborators at the Buck Institute for Research on Aging.
They shared new data highlighting how CD38 inhibition may enhance cognitive performance during aging by modulating NAD metabolism – reinforcing its potential as a key target in age related diseases.
Our ongoing collaboration with the Buck Institute is helping us explore the broader therapeutic potential of this target across multiple indications beyond our current focus, including in brain function.
👏 Huge thanks to our scientific team and collaborators at the Buck for their groundbreaking work and shared commitment to advancing aging science.
hashtagAgingResearch hashtagCD38 hashtagNADMetabolism hashtagBrainAging hashtagDrugDiscovery hashtagTranslationalScience hashtagBiologyOfAging hashtagJuvenescence hashtagLongevityScience